Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Peginterferon Alfa-2a Injection bulk supplier for pharma manufacturers

Peginterferon Alfa-2a Injection 90 mcg, 135 mcg, 180 mcg Suppliers & Bulk Manufacturers

Available Forms: Pre-filled syringe (subcutaneous)

Available Strengths: 90 mcg, 135 mcg, 180 mcg

Pack Sizes: 1 or 4 pre-filled syringes

Originator reference: Pegasys (brand names belong to their owners and are shown only to identify the originator medicine)

Category: Hepatitis

Peginterferon alfa-2a (reference Pegasys) is a weekly injection used for chronic hepatitis B and hepatitis D, and by specialists for some blood disorders such as polycythaemia vera. It comes as 90, 135 and 180 mcg pre-filled syringes. PharmaTradz connects hospital, tender and distributor buyers with GMP-certified manufacturers and licensed exporters, and checks the documents needed for the destination market.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Peginterferon Alfa-2a Injection? List it or send an offer →

Product Description:

Peginterferon alfa-2a is interferon alfa-2a joined to a large polyethylene glycol (PEG) molecule. Interferon boosts the body's antiviral and immune response; the PEG slows its removal, so one injection a week is enough instead of several. It is given as a subcutaneous injection from a pre-filled syringe.

Today its main uses are chronic hepatitis B, where a fixed 48-week course can lead to lasting control without lifelong tablets, and chronic hepatitis D, where options are limited. Haematologists also use it for myeloproliferative disorders such as polycythaemia vera and essential thrombocythaemia, including in pregnancy. Its use in hepatitis C has largely ended since oral direct-acting antivirals arrived.

Sourcing notes. Availability has narrowed in several markets as hepatitis C demand fell, and buyers now often look for alternative sources or imported stock. It is a cold-chain biologic, so temperature control and batch release documents matter. Interferon alfa-2b is also listed on PharmaTradz.

Peginterferon Alfa-2a Injection — third party manufacturing & bulk supply

Peginterferon Alfa-2a Injection 90 mcg, 135 mcg, 180 mcg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Peginterferon Alfa-2a Injection is supplied as Pre-filled syringe (subcutaneous) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Peginterferon Alfa-2a Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Peginterferon Alfa-2a Injection →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Chronic hepatitis B and hepatitis D, and by specialists for polycythaemia vera and essential thrombocythaemia.

Pegasys. It comes as 90, 135 and 180 mcg pre-filled syringes.

Once a week under the skin.

No. They are different interferon molecules with different PEG chains and dosing. They should not be substituted without the prescriber's agreement.

Related Products

Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir

Strength:
Ombitasvir 12.5 mg / Paritaprevir 75 mg / Ritonavir 50 mg (tablet)+ Dasabuvir 250 mg (tablet)

Form: Tablet

Originator reference: Viekira Pak® (US); Viekirax® + Exviera® (EU)

View Details
Ribavirin

Strength:
Tablet:200 mg, 400 mg, 600mg; Capsule:200 mg; Solution:40 mg/mL

Form: Tablets, Capsules and Oral Solution

Originator reference: Rebetol®, Copegus®, Virazole®(EU & US)

View Details
Adefovir Dipivoxil

Strength:
10 mg

Form: Oral tablets

Originator reference: Hepsera® (EU & US)

View Details
Tenofovir Alafenamide (TAF)

Strength:
25 mg TAF per tablet

Form: Tablet

Originator reference: Vemlidy (EU & US)

View Details
Human Normal Immunoglobulin

Strength:
IVIG: 5%, 10%, 16%, 20%; SCIG: 20%

Form: (IVIG) & (SCIG)

Originator reference: -

View Details
Daclatasvir/ Sofosbuvir

Strength:
Daclatasvir 60 mg + Sofosbuvir 400 mg

Form: Tablet

Originator reference: -

View Details
Daclatasvir

Strength:
30 mg, 60 mg

Form: Tablet

Originator reference: Daklinza® (US & EU)

View Details
Peginterferon Alfa Injection

Strength:
120 mcg, 150 mcg, 180 mcg

Form: Injection

Originator reference: Pegasys® (US & EU), PegIntron® (EU)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us